health

The National Institute for Health and Clinical Excellence (Nice) has banned another breast cancer drug from routine NHS use.

For those seeking a break from the norm, Owain Thomas discovers the IPMI market is both growing strongly and increasingly dynamic

The government's assertion that the National Health Service is inefficient and ineffective in treating cancer has been challenged by academics.

This genetic illness affects about one in 800 people in the UK. Mary Randell explains how advisers can offer cover for it

Now Health International has introduced a flexible currency facility for customers in around 200 countries.

The international private medical insurance (IPMI) market could be subject of a series of mergers and acquisitions between providers, according to one insurer in the sector.

MPs have demanded that the new public health body for England must be independent of government while saying nudges to encourage better personal health will not work.

Paycare has launched a new healthcare benefit cash plan for employers to offer their staff.

It appears the Chair of the NHS Commissioning Board pays for private care after he admitted to not using the NHS.

Aviva has overhauled its cancer coverage for both individual and group private medical insurance (PMI) schemes.